SmartPill nears market after completing gastroparesis trials
This article was originally published in Clinica
Executive Summary
Moving nearer to making its market debut, SmartPill has successfully completed clinical trials of its ingestible capsule and monitoring system for the diagnosis of gastroparesis, a condition characterised by the inability to empty the stomach.